These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36686189)

  • 21. Therapeutic potential of cannabinoids in schizophrenia.
    Kucerova J; Tabiova K; Drago F; Micale V
    Recent Pat CNS Drug Discov; 2014 Apr; 9(1):13-25. PubMed ID: 24605939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Mechanism and Cannabinoid Pharmacology.
    Schurman LD; Lu D; Kendall DA; Howlett AC; Lichtman AH
    Handb Exp Pharmacol; 2020; 258():323-353. PubMed ID: 32236882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
    Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
    Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel phytocannabinoids from Ganoderma by label-free dynamic mass redistribution assay.
    Zhou H; Peng X; Hou T; Zhao N; Qiu M; Zhang X; Liang X
    J Ethnopharmacol; 2020 Jan; 246():112218. PubMed ID: 31494202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocannabinoid System: Chemical Characteristics and Biological Activity.
    Rezende B; Alencar AKN; de Bem GF; Fontes-Dantas FL; Montes GC
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37017445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges.
    Hassan FU; Liu C; Mehboob M; Bilal RM; Arain MA; Siddique F; Chen F; Li Y; Zhang J; Shi P; Lv B; Lin Q
    Front Immunol; 2023; 14():1285052. PubMed ID: 38111585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
    Anand P; Whiteside G; Fowler CJ; Hohmann AG
    Brain Res Rev; 2009 Apr; 60(1):255-66. PubMed ID: 19150370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The endocannabinoid system, cannabinoids, and pain.
    Fine PG; Rosenfeld MJ
    Rambam Maimonides Med J; 2013; 4(4):e0022. PubMed ID: 24228165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of the Cannabinoid System in Pain Control: Basic and Clinical Implications.
    Wolf J; Urits I; Orhurhu V; Peck J; Orhurhu MS; Giacomazzi S; Smoots D; Piermarini C; Manchikanti L; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Jun; 24(7):35. PubMed ID: 32506272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Insights Into Peptide Cannabinoids: Structure, Biosynthesis and Signaling.
    Riquelme-Sandoval A; de Sá-Ferreira CO; Miyakoshi LM; Hedin-Pereira C
    Front Pharmacol; 2020; 11():596572. PubMed ID: 33362550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in cannabis research from a pharmaceutical chemist's point of view].
    Müller CE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):818-824. PubMed ID: 31161229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocannabinoids and cannabinoid receptor genetics.
    Onaivi ES; Leonard CM; Ishiguro H; Zhang PW; Lin Z; Akinshola BE; Uhl GR
    Prog Neurobiol; 2002 Apr; 66(5):307-44. PubMed ID: 12015198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids.
    Grotenhermen F
    Curr Drug Targets CNS Neurol Disord; 2005 Oct; 4(5):507-30. PubMed ID: 16266285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid and endocannabinoid system: a promising therapeutic intervention for multiple sclerosis.
    Khan H; Ghori FK; Ghani U; Javed A; Zahid S
    Mol Biol Rep; 2022 Jun; 49(6):5117-5131. PubMed ID: 35182322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.